27 Results for "

factor IX

" in MedChemExpress (MCE) Product Catalog:
Products (27)

27 Results for "factor IX" in MCE Product Catalog:

20
20 Cited Publications
製品番号: HY-145405
CAS 番号: 1220890-25-4
純度:  99.91%
Target:  

Liposome

研究分野:  

Others

C12-200 is a type of ionizable cationic lipid and helper lipid commonly used for mRNA delivery. In the hemophilia B mouse model, mRNA encoding human erythropoietin (EPO) and coagulation factor IX (FIX) can be successfully delivered and expressed using C12-200. C12-200 is utilized in research related to hemophilia B .
loading...
    loading...
1
1 Cited Publications
製品番号: HY-P70231
純度:  ≥ 95%, as determined by reducing SDS-PAGE.
別名: F9; Autoprothrombin IIA; Coagulation factor IX; Coagulant factor IX; FIX; Christmas Disease; Plasma Thromboplastic Component; Hemophilia B; Plasma Thromboplastin Component; factor IX F9; Christmas factor; factor IX; PTC; factor 9; Truncated Coagulation Fa
Species:  
Human
Source:  
HEK293
loading...
    loading...
製品番号: HY-P9940
CAS 番号: 1610943-06-0
別名: ACE-910; RG6013
Target:  

Factor VIII

研究分野:  

Cardiovascular Disease

Emicizumab is a bispecific monoclonal antibody that bridges activated factor IX and factor X to replace the function of missing activated factor VIII, thereby restoring hemostasis. Emicizumab can be used for hemophilia A research .
loading...
    loading...
製品番号: HY-E70541B
CAS 番号: 9001-28-9
研究分野:  

Cardiovascular Disease

Canine Factor IX is a functional coagulation factor. Canine Factor IX shortens whole blood clotting time and activated partial thromboplastin time, and restores coagulation function. After intramuscular administration via rAAV vector in hemophilia B dogs, Canine Factor IX maintains a sustained circulating level for at least 1 year, partially corrects the hemophilia B phenotype in a dose-dependent manner, and its plasma expression persists for more than 17 months. Canine Factor IX is applicable to relevant research on hemophilia B .
loading...
    loading...
製品番号: HY-14854
CAS 番号: 867257-26-9
純度:  98.65%
別名: ATI-5923
Target:  

VKOR

研究分野:  

Cardiovascular Disease

Tecarfarin (ATI-5923) is an orally active and non-competitive vitamin K epoxide reductase (VKOR) antagonist, and impairs the activation of the vitamin K-dependent clotting factors II, VII, IX and X . Tecarfarin has the antithrombotic activity .
loading...
    loading...
製品番号: HY-107966A
CAS 番号: 37270-89-6
別名: Nadroparin calcium (MW 3600-5000)
Heparin (Nadroparin) calcium (MW 3600-5000) is an anticoagulant which binds reversibly to antithrombin III (ATIII) to form a heparin-antithrombin III complex. The complex binds to and irreversibly inactivates thrombin and other activated clotting factors IX, X, XI, and XII and prevents the transformation of fibrinogen to fibrin .
loading...
    loading...
製品番号: HY-122142A
CAS 番号: 127428-47-1
別名: S-2366 (hydrochloride)
研究分野:  

Others

Pyr-​Pro-​Arg-​pNA (S-2366) hydrochloride is a chromogenic peptidyl substrate, and a noncompetitive inhibitor that occupies the active sites of FXIa and FXIa-LC to block factor IX activation. Pyr-​Pro-​Arg-​pNA hydrochloride functions as a hydrolyzable substrate for FXIa’s catalytic domain, human APC, murine APC, and purified plasma kallikrein .
loading...
    loading...
製品番号: HY-P4243A
Target:  

Ser/Thr Protease

研究分野:  

Others

Dansyl-Glu-Gly-Arg-Chloromethylketone TFA is a protease inhibitor, and inhibits serine/threonine proteases. Dansyl-Glu-Gly-Arg-Chloromethylketone TFA inhibits activated porcine factor IX .
loading...
    loading...
製品番号: HY-174232
研究分野:  

Cancer

EGFR/CA-IX-IN-1 (Compound 14) is a dual inhibitor against epidermal growth factor receptor (EGFR) and carbonic anhydrase IX (CA-IX) with IC50 values of 5.92 nM and 63 nM, respectively. EGFR/CA-IX-IN-1 shows strong cytotoxicity against breast cancer cells (MDA-MB-231, MCF-7) with IC50 values of 5.78 μM and 8.05 μM, respectively. EGFR/CA-IX-IN-1 inhibits the catalytic activity of CA-IX, up-regulates BAX/Bcl-2, activates caspases, and arrests the cell cycle at the G1 phase. EGFR/CA-IX-IN-1 is promising for research of breast cancer .
loading...
    loading...
製品番号: HY-P4243
CAS 番号: 69024-84-6
Target:  

Ser/Thr Protease

研究分野:  

Others

Dansyl-Glu-Gly-Arg-Chloromethylketone is a protease inhibitor, and inhibits serine/threonine proteases. Dansyl-Glu-Gly-Arg-Chloromethylketone inhibits activated porcine factor IX .
loading...
    loading...
製品番号: HY-E70541A
CAS 番号: 9001-28-9
研究分野:  

Cardiovascular Disease

Bovine Factor IX is prepared from freshly collected bovine plasma. Factor IX activated by the Factor VIIa/tissue factor/phospholipid complex is responsible for the activation of Factor X to Factor Xa .
loading...
    loading...
製品番号: HY-107966
CAS 番号: 37270-89-6
別名: Nadroparin calcium (MW 15000-19000)
Heparin calcium (MW 15000-19000) is an anticoagulant which binds reversibly to antithrombin III (ATIII) to form a heparin-antithrombin III complex. The complex binds to and irreversibly inactivates thrombin and other activated clotting factors IX, X, XI, and XII and prevents the transformation of fibrinogen to fibrin .
loading...
    loading...
製品番号: HY-122142
CAS 番号: 72194-57-1
別名: S-2366
Pyr-​Pro-​Arg-​pNA (S-2366) is a chromogenic peptidyl substrate, and a noncompetitive inhibitor that occupies the active sites of FXIa and FXIa-LC to block factor IX activation. Pyr-​Pro-​Arg-​pNA functions as a hydrolyzable substrate for FXIa’s catalytic domain, human APC, murine APC, and purified plasma kallikrein .
loading...
    loading...
製品番号: HY-112935
CAS 番号: 181054-95-5
別名: BAX326; Coagulation factor IX [Recombinant]; BeneFIX

Target:  

Ser/Thr Protease

研究分野:  

Others

Nonacog alfa (BAX326) is a recombinant human factor IX that can be used for the research of haemophilia B .
loading...
    loading...
製品番号: HY-121244
CAS 番号: 117-52-2
Coumafuryl is a kind of coumarin rodenticide. Coumafuryl inhibits the metabolic cycle of vitamin K that causes the interference with protein biosynthesis of vitamin K-dependent coagulant factors (II, VII, IX, and X factors) in the liver .
loading...
    loading...
製品番号: HY-E70393J
Target:  

Factor XI

研究分野:  

Others

Bovine Factor XIa is an enzyme, which is involved in the intrinsic pathway of blood coagulation. Bovine Factor XIa is highly selective and exhibits a minimal extended substrate recognition site of at least five residues long. Bovine Factor XIa is reactive as Bovine Factor IXa (HY-E70393I) does, that it cleaves all the peptides bearing factor IX activation site sequences .
loading...
    loading...
製品番号: HY-P991213
別名: RIXubis

Target:  

Factor XI

研究分野:  

Cardiovascular Disease

Nonacog gamma is a coagulation factor IX (FIX) supplement. Nonacog gamma activates coagulation factor X (FX), promotes the generation of thrombin, and then converts fibrinogen into fibrin, forming a stable blood clot to exert hemostatic activity. Nonacog gamma is promising for research of hemophilia B .
loading...
    loading...
製品番号: HY-P9940A
Target:  

Factor VIII

研究分野:  

Cardiovascular Disease

Emicizumab (Anti-F9 & Factor IX) is a bispecific monoclonal antibody that bridges activated factor IX and factor X to replace the function of missing activated factor VIII, thereby restoring hemostasis. Emicizumab (Anti-F9 & Factor IX) can be used for hemophilia A research .
loading...
    loading...
製品番号: HY-14854A
CAS 番号: 1004551-83-0
別名: ATI-5923 sodium
Target:  

VKOR

研究分野:  

Cardiovascular Disease

Tecarfarin (ATI-5923) sodium is an orally active VKOR inhibitor with an IC50 of 0.67 μM against VKORC1. Tecarfarin sodium blocks the post-translational modification of vitamin K-dependent coagulation factors II, VII, IX and X, reducing their levels and activities. Tecarfarin sodium prolongs prothrombin time, attenuates venous and arterial thrombosis, increases ear incision bleeding volume, and exerts reversible anticoagulant effects. Tecarfarin sodium is applicable to research related to arterial and venous thrombosis as well as other diseases requiring anticoagulation .
loading...
    loading...
製品番号: HY-14854R
CAS 番号: 867257-26-9
別名: ATI-5923 (Standard)
研究分野:  

Cardiovascular Disease

Tecarfarin (ATI-5923) (Standard) is the analytical standard of Tecarfarin. This product is intended for research and analytical applications. Tecarfarin is an orally active VKOR inhibitor with an IC50 of 0.67 μM against VKORC1. Tecarfarin blocks the post-translational modification of vitamin K-dependent coagulation factors II, VII, IX and X, reducing their levels and activities. Tecarfarin prolongs prothrombin time, attenuates venous and arterial thrombosis, increases ear incision bleeding volume, and exerts reversible anticoagulant effects. Tecarfarin is applicable to research related to arterial and venous thrombosis as well as other diseases requiring anticoagulation .
loading...
    loading...